Introduction
The technology for introducing recombinant genes into mammals has been available only since 1980. At that time, five independent research groups succeeded in transferring genes to produce the first "transgenic" mice (see review by Palmiter and Brinster, 1986) . Subsequently, constructs encoding growth-regulating genes, such as growth hormone (GH) or growth hormone-releasing factor ( GHRF) , were transferred to produce "super" mice (Palmiter et al., 1982) . These results prompted the development of microinjection techniques for farm animals (Wall et al., 19851 , which were then used to produce transgenic livestock (Ham-J. Anim. Sci. 1994 . 72:1242 -1246 mer et al., 1985 . Most of the gene transfer experiments carried out with farm animals during the late 1980s attempted t o manipulate growth and related production characteristics such as feed efficiency. By the end of the 1980s, the introduction of 16 genes had been reported for the three major livestock species (Purse1 et al., 1989) .
Gene transfer into farm animals is required to evaluate the potential for improving production efficiency, carcass quality, and disease resistance of livestock. It is well established that administration of exogenous porcine somatotropin (pST) to pigs at different stages of growth and development (e.g., between 25 and 110 kg) improves performance and results in alterations in body composition (Campbell et al., 1988 Smith and Kasson, 1990) . However, little is known regarding body or carcass composition and lipid composition of transgenic farm animals that are expressing a GH transgene. Therefore, the purpose of this study was to determine what effect the expression of a recombinant bovine (b) GH . Subsequent generations were produced by artificial insemination of nontransgenic crossbred females with fresh or frozen epididymal spermatozoa recovered from bGH transgenic boars after euthanasia. Presence of the bGH transgene was established by hybridization of dot blots of DNA from tail biopsies . Expression of the bGH transgene was established by radioimmunoassay of plasma collected at 1 wk of age or older using a bGH radioimmunoassay that did not measure pGH . Control pigs were siblings that did not contain the transgene. Plasma bGH concentrations were > 1,000 ng/mL in transgenic pigs of the 31-04 line and approximately 60 ng/mL in transgenic pigs of the 37-06 line . Carcass composition was not affected by the different lines of transgenic founder. Pigs were weaned at 4 to 8 wk of age and had ad libitum access to a corn-soybean meal diet ( control sample was a lipid extract from a randomly selected loin sample analyzed in the study. Methylation and preparation of samples for GLC analysis were previously described . Analysis of the fatty acid composition was performed on a gas chromatograph (Model 5880A, Hewlett-Packard, Avondale, PA) designed to accommodate a capillary column. The gas chromatographic technique of Slover and Lanza (1979) was followed to quantify fatty acids resolved on a 30-m SP 2330 fused silica capillary column (Supelco, Bellefonte, PA). Helium served as the carrier and makeup gas (column flow rate = .8 m u m i n and makeup flow rate = 30 mL/ min). Temperatures of the injector, oven, and detector were 200, 170, and 200°C, respectively. Cholesterol Analysis. Cholesterol was converted to a trimethylsilyl ether derivative; stigmasterol ( .40 mg/ mL) served as the internal standard. The derivatizing procedure and sample preparation were previously described .
Analysis of the cholesterol was performed on a gas chromatograph (Hewlett-Packard) designed to accommodate a packed column. A 183-cm x 4-mm glass column (Alltech Associates, Deerfield, IL) packed with 3% OV-17 on Gas Chrom Q (100/120) was used to resolve the cholesterol and stigmasterol peaks. Helium served as the carrier gas; column flow rate was = 50 mL/min. Temperatures of the injector, oven, and detector were 300, 270, and 300°C, respectively.
Data Analysis. Data were analyzed by the least squares analysis of variance using the GLM routine (SAS, 1985) to determine the significance of variation between transgenic and controls at the five different weight groups for a 2 x 5 factorial arrangement, which included treatment x weight group interactions. The comparison of weight groups was based on linear and quadratic orthogonal polynomials. 
Results and Discussion
Feed intake was not recorded for these pigs; however, from previous work with similar transgenic pigs (Purse1 et al., 1989) a 20% reduction in feed intake could be expected for transgenic pigs. Average daily gains (not in tabular form) were not significantly different between control and transgenic pigs in the present experiment. Backfat thickness and longissimus muscle area (LMA) were measured (not in tabular form) at the 10th rib for only the pigs in the 48-, 68-, and 92-kg weight groups. Backfat increased from 16.0 mm t o 22.4 mm for the control ( C ) pigs. Conversely, backfat decreased from 8.1 to 2.8 mm for the bGH-transgenic ( T) pigs. The LMA increased in both the control and bGH-T pigs with increasing body weight and no difference at any of the weight groups was detected between bGH-T and sibling C pigs.
Carcass fat deposition followed a different pattern for bGH-T pigs and C pigs (Table 2) . Total carcass lipid increased linearly ( 190%) in the C pigs from 14-to 92-kg live weight, whereas for the bGH-T pigs total carcass lipid only increased (32%) from 14-to 48-kg live weight and then decreased (45%) from 48 to 92 kg (overall 27% decrease from 14 to 92 kg).
At 14-kg body weight, carcasses from bGH-T pigs contained 38% less fat than those from C pigs. At 28 kg, bGH-T pigs had 38% less total carcass fat; at 48 kg, 48% less total carcass fat; at 68 kg, 78% less total carcass fat; and at 92 kg, 85% less carcass fat than C pigs. In fact, some of the 92-kg bGH-T pigs contained less than 3% total carcass fat. Studies involving the effect of daily pST administration to pigs reported decreases in carcass fat, but not of this magnitude (Campbell et al., 1990; Caperna et al., 1990) . Total cholesterol content of the ground carcass tissue was not different between bGH-T and C pigs at any of the designated weights; however, with increasing live weight ( 14 to 92 kg), cholesterol content decreased for both C and bGH-T pigs (23% C pigs; 28% bGH-T pigs). Carcass weight had both a negative linear and a positive quadratic effect on cholesterol content of the carcass. Similar results for muscle and adipose tissue were found in pigs receiving daily administration of pST (Solomon, 1992) . Although the role of dietary cholesterol intake in humans is questionable, the general recommendation is to limit intake to 100 mg/ 1,000 kcal, not to exceed 300 mg/d (American Heart Association, 1986).
Carcasses from bGH-T pigs consistently contained less ( P < .O 1 ) total saturated fatty acids ( SFA) than those from C pigs at each slaughter weight (Table 2) . A 137% linear increase in total SFA was observed in C pigs with increasing live weight (14 to 92 kg), compared with a 40% decrease in total SFA for bGH-T pigs. These differences in SFA were mostly a result of changes in C16:O (palmitic acid), C18:O (stearic acid), and C14:O (myristic acid). Margaric (C17:O) and arachidic (C20:O) acids were also present, but in very small quantities. The bGH-T pigs from all weight groups were devoid of C20:0, whereas the only C pigs that did not contain C20:O were the 14-kg pigs. Palmitic acid accounted for 62% of the total detectable SFA in the C pigs (92 kg weight group), compared with 66% in bGH-T pigs. Stearic acid accounted for 34% of the total SFA in the C pigs (92-kg weight group), compared with 30% in bGH-T pigs. A 104% increase was observed for palmitic acid in C pigs with increasing live weight from 14 to 92 kg, compared with a 47% reduction in bGH-T pigs. A 258% linear increase was observed for stearic acid in C pigs with increasing live weight, compared with a 10% reduction in bGH-T pigs. Myristic acid increased by 80% in C pigs, compared with a 63% decrease in bGH-T pigs with increasing live weight. The administration of exogenous pST to growing pigs resulted in lean tissue containing 40%' less SFA and subcutaneous fat containing 33% less SFA than controls (Solomon, 1992) . The majority of this difference was attributed to less palmitic and stearic acids in the carcass tissue from pST pigs. Clark et al. (1992) reported similar results regarding SFA content of lean and subcutaneous fat of pST-treated pigs.
Both myristic acid and palmitic acid have been reported to be hyperlipidemic and hypercholesterolemic (Keys et al., 1965) . Human consumption of hypercholesterolemic fatty acids has come under attack by health professionals (NRC, 1988) . Bona-mone and Grundy (1988) demonstrated that a diet high in stearic acid did not elevate plasma levels of low-density lipoprotein cholesterol, perhaps because it is poorly digested and can be easily desaturated to oleic acid (Keys et al., 1965) . At 14-kg body weight, carcasses from bGH-T pigs contained 44% less SFA than those from C pigs. At 28 kg, bGH-T pigs had 42% less SFA; at 48 kg, bGH-T pigs had 55% less SFA; at 68 kg, bGH-T pigs had 78% less SFA; and at 92 kg, bGH-T pigs contained 85% less SFA than did C pigs. From a dietary viewpoint, carcass tissue from bGH-T pigs reflects a much more favorable (lower) quantity of SFA.
Carcasses from bGH-T pigs contained less total monounsaturated fatty acids ( MUFA) than did those from C pigs at each processing weight ( Table 2 ). The fatty acids that constituted the MUFA were palmitoleic (ClG:l-cis), palmitelaidic (ClG:l-trans), oleic (C18:1), and cis-ll-eicosenoic (C20:l) acid. Oleic acid was the most abundant MUFA in the total lipid fraction and more cis-Cl6:l was present. The bGH-T pigs contained 87%' less oleic acid than C pigs (92 kg live weight). The trend was for the quantity of MUFA to increase with increasing body weight in C pigs. A MUFA dilution effect was observed in bGH-T pigs after 48-kg live weight that was the same pattern for total carcass lipid deposition. At 14-kg body weight, carcasses from bGH-T pigs contained 48% less MUFA; at 28 kg, 46% less MUFA; at 48 kg, 59% less MUFA; at 68 kg, 79% less MUFA, and at 92 kg, 91% less MUFA than those from C pigs. Solomon (1992) found a 37% reduction in lean tissue MUFA and a 24% reduction in subcutaneous fat MUFA when exogenous pST was administered daily to growing pigs. Clark et al. (1992 reported similar results regarding the MUFA content of lean and subcutaneous fat of pSTtreated pigs. Oleic acid has been reported t o be hypolipidemic, reducing both cholesterol and LDL triglycerides (Grundy, 19861 , and for that reason it is not considered to be an undesirable dietary fatty acid.
Mattson and Grundy ( 198 5 1 demonstrated that oleic acid had the ability t o reduce low-density lipoprotein cholesterol. Although C pigs contained a higher proportion of oleic acid, a lower fatty acid content, regardless of the type of fatty acid, would still be more desirable.
Significant differences in the percentage of polyunsaturated fatty acids (PUFA) were observed in the carcass tissue from C and T pigs (Table 2) . Carcass tissue from bGH-T pigs (92-kg live weight) contained 66% less C18:2 (linoleic acid), 88%, less C18:3 (linolenic acid), and 75% less C20:4 (arachidonic acid), for an overall 67% reduction in total PUFA, than did that from C pigs. Polyunsaturated fatty acids have received much less criticism with regard to dietary detriments; in fact, they have been reported to be hypolipidemichypocholesterolemic (NRC , 198 8) .
At 14-kg slaughter weight, carcasses from bGH-T pigs contained 38% less PUFA; a t 28 kg, 24% less PUFA; at 48 kg, 22% less PUFA; at 68 kg, 53% less PUFA, and at 92 kg, 66% less PUFA than those from C pigs. The trend was for PUFA to increase with increasing live weight in C pigs and to decrease with increasing weight in bGH-T pigs. Administration of exogenous pST had a minor effect on PUFA content of muscle or adipose tissue of pigs (Clark et al., 1992; Solomon, 1992) .
Implications
Carcass tissue from bovine growth hormone transgenic pigs reflects much more favorable levels of fatty acids than does that from control pigs when considering dietary health recommendations and concerns. If levels of growth hormone secretion could be precisely regulated during the rapid growth phase of market hogs, it might be possible to provide consumers with an ultra-low-fat pork product.
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